|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 1997;64:257-258
© 1997 The Society of Thoracic Surgeons
Division of Cardiothoracic Surgery, Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425-1095
| The first 20% of the full text of this article appears below. |
See also page 255.
This case report by Burger and associates raises two interesting and related questions. The first is whether there is an adequate anticlotting regimen for mechanical valves in the pulmonary position. Burger and associates switched their patient from aspirin to warfarin and suggest that warfarin will provide more effective anticlotting prophylaxis. Extrapolation of the data available in adults with left-sided mechanical valves, where warfarin is more effective than antiplatelet agents, makes it tempting to conclude Burger and associates are correct. However, because the total number of patients with mechanical pulmonary valves is small, there is too little information available to make any meaningful comparison of warfarin and antiplatelet agents in this setting. The sum of the information available in case reports and
Related Article
Ann. Thorac. Surg. 1997 64: 255-257.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |